Soligenix
SNGX
#10882
Rank
ยฃ4.11 M
Marketcap
ยฃ0.28
Share price
-0.29%
Change (1 day)
-86.55%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2026 (TTM): -ยฃ8.7 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ8.79 Million a decrease over its 2024 earnings that were of -ยฃ6.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ8.7 Million-1.08%
2025 -ยฃ8.79 Million26.72%
2024 -ยฃ6.94 Million22.96%
2023 -ยฃ5.64 Million-45.74%
2022 -ยฃ10.4 Million11.88%
2021 -ยฃ9.29 Million-32.37%
2020 -ยฃ13.74 Million83.18%
2019 -ยฃ7.5 Million11.57%
2018 -ยฃ6.72 Million19.29%
2017 -ยฃ5.64 Million33%
2016 -ยฃ4.24 Million-19.7%
2015 -ยฃ5.28 Million5.16%
2014 -ยฃ5.02 Million
2010 -ยฃ5.67 Million26.12%
2009 -ยฃ4.49 Million75.1%
2008 -ยฃ2.57 Million-45.38%
2007 -ยฃ4.7 Million-22.84%
2006 -ยฃ6.09 Million66.15%
2005 -ยฃ3.67 Million-16.65%
2004 -ยฃ4.4 Million13.28%
2003 -ยฃ3.88 Million-11.88%
2002 -ยฃ4.4 Million-59.44%
2001 -ยฃ10.85 Million378.18%
2000 -ยฃ2.27 Million-38.53%
1999 -ยฃ3.7 Million-18.43%
1998 -ยฃ4.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.26 B-222,070.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ7.85 B-90,591.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ5.68 B-65,535.84%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-ยฃ13.47 Million 55.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ30.98 Million 256.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.68 B-19,503.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-ยฃ2.05 Million-76.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ43.83 M-604.96%๐Ÿ‡บ๐Ÿ‡ธ USA